Brought to you by:
Final Meet the Experts session is July 15
Practicing vascular surgeons, learn all about preventing and managing type II endoleaks—a common situation faced by specialists—from the experts on Thursday, July 15. Benjamin Jackson, MD, will moderate the session, alongside panelists Wei Zhou, MD, and Sunita Srivastava, MD. Participation…
WFVS undergoes transformation, looks for vascular ’haves‘ to better help ‘have nots‘
The World Federation of Vascular Societies (WFVS) has entered a new era of transformation, seeking to better pave the way for disparate vascular surgeons and societies to disseminate the latest science and best practices to every corner of the globe.…
Town Halls to address wellness, appropriate use
The Society for Vascular Surgery (SVS) has scheduled two Town Halls for the summer—one to cover vascular surgeon wellness programs (July 13) and the other to discuss the SVS’ first-ever appropriate use criteria (AUC) guidelines being developed on intermittent claudication…
Fighting the good fight: The case for multidisciplinary limb salvage in face of increasing diabetes, diversifying nation
Dramatic increases in rates of diabetes—particularly among Black females—through 2060 underscore the importance of a multidisciplinary team approach to limb salvage, according to Vincent Rowe, MD, professor of vascular surgery and endovascular therapy in the Keck School of Medicine at…
Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical
Surmodics recently announced that it has acquired privately-held Vetex Medical Limited, expanding the company’s thrombectomy portfolio with a second Food and Drug Administration (FDA) 510(k)-cleared device, the ReVene thrombectomy catheter. The ReVene mechanical thrombectomy catheter is specifically designed to remove large,…
Janssen submits new drug application to FDA for rivaroxaban to treat VTE in pediatric patients
The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced it has submitted a new drug application (NDA) to the Food and Drug Administration (FDA) for the use of Xarelto (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment…
SVS releases updated clinical practice guidelines covering carotid disease
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines accompanied by an implementation document on the management of patients with extracranial carotid artery disease. The documents, both published in the Journal of Vascular Surgery, aim to use the…
A lifetime of achievement: Former SVS president looks back on career milestones
The first time Bruce A. Perler, MD, attended the Southern Association for Vascular Surgery (SAVS) annual meeting, he was a young faculty member who had already started developing the keen interest in carotid disease for which he is now well…
SVS clinical practice guidelines on popliteal artery aneurysms published
The Society for Vascular Surgery (SVS) has released new clinical practice guidelines to ensure that patients with popliteal artery aneurysms receive appropriate treatment and care. Aneurysms of the popliteal artery are the most common aneurysms outside of the brain and…
SVS Town Hall on June 30 hones in on value of an OBL
The next Society for Vascular Surgery (SVS) Town Hall will focus on the value of an office-based lab (OBL) to the healthcare system, patients and physicians. The webinar, sponsored by the SVS Section on Outpatient & Office Vascular Care (SOOVC),…